Literature DB >> 6777774

4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

T K Sawyer, P J Sanfilippo, V J Hruby, M H Engel, C B Heward, J B Burnett, M E Hadley.   

Abstract

alpha-Melanocyte-stimulating hormone (alpha-MSH) reversibly darkens frog skins by stimulating melanosome movement (dispersion) within melanophores. Heat-alkali treatment of alpha-MSH results in prolonged biological activity of the hormone. Quantitative gas chromatographic analysis of the hydrolyzed heat-alkali-treated peptide revealed partial racemization particularly at the 4(methionine) and 7(phenylalanine) positions. [Nle4]-alpha-MSH, a synthetic analogue of alpha-MSH, reversibly darkens frog skins and also exhibits prolonged activity after heat-alkali treatment. Synthesis of [Nle4, D-Phe7]-alpha-MSH provided an analogue with prolonged biological activity identical to that observed with heat-alkali-treated alpha-MSH or [Nle4]-alpha-MSH. [Nle4, D-Phe7]-alpha-MSH was resistant to enzymatic degradation by serum enzymes. In addition, this peptide exhibited dramatically increased biological activity as determined by frog skin bioassay, activation of mouse melanoma adenylate cyclase, and stimulation of mouse melanoma cell tyrosinase activity. This Nle4, D-Phe7 synthetic analogue of alpha-MSH is a very porent melanotropin, 26 times as potent as alpha-MSH in the adenylate cyclase assay. The resistance of the peptide to enzymatic degradation and its extraordinarily potent and prolonged biological activity should make this analogue of alpha-MSH an important molecular probe for studying the melanotropin receptors of both normal and abnormal (melanoma) melanocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777774      PMCID: PMC350149          DOI: 10.1073/pnas.77.10.5754

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Iodination associated inactivation of beta-melanocyte stimulating hormone.

Authors:  C B Heward; Y C Yang; T K Sawyer; M D Bregman; B B Fuller; V J Hruby; M E Hadley
Journal:  Biochem Biophys Res Commun       Date:  1979-05-14       Impact factor: 3.575

2.  ACTH and MSH peptides in the human adult and fetal pituitary gland.

Authors:  R E Silman; T Chard; J Landon; P J Lowry; I Smith; I M Young
Journal:  Front Horm Res       Date:  1977       Impact factor: 2.606

3.  Effects of chloramine T and iodination on the biological activity of melanotropin.

Authors:  C B Heward; Y C Yang; J F Ormberg; M E Hadley; V J Hruby
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

4.  Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.

Authors:  T Huntington; M E Hadley
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

5.  The extent of racemization of some amino acids in dilute alkali-treated protein and soil humic and fulvic acid.

Authors:  G E Pollock; L H Frommhagen
Journal:  Anal Biochem       Date:  1968-07       Impact factor: 3.365

6.  Adenosine and divalent cation effects on S-91 melanoma adenylate cyclase.

Authors:  M D Bregman; T K Sawyer; M E Hadley; V J Hruby
Journal:  Arch Biochem Biophys       Date:  1980-04-15       Impact factor: 4.013

7.  Synthesis and biological activity of camel and bovine beta-melanotropins.

Authors:  S Lemaire; D Yamashiro; C H Li
Journal:  J Med Chem       Date:  1976-03       Impact factor: 7.446

8.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

9.  Synthesis of alpha- and beta-melanocyte stimulating hormones.

Authors:  Y C Yang; V J Hruby; C B Heward; M E Hadley
Journal:  Int J Pept Protein Res       Date:  1980-02

10.  Studies on the irreversible nature of prolactin binding to receptors.

Authors:  A A van der Gugten; M J Waters; G S Murthy; H G Friesen
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

View more
  137 in total

1.  A sucrose-derived scaffold for multimerization of bioactive peptides.

Authors:  Venkataramanarao Rao; Ramesh Alleti; Liping Xu; Narges K Tafreshi; David L Morse; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

4.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

5.  Design, synthesis, and validation of a branched flexible linker for bioactive peptides.

Authors:  Martina E Bowen; Yasunari Monguchi; Rajesh Sankaranarayanan; Josef Vagner; Lucinda J Begay; Liping Xu; Bhumasamudram Jagadish; Victor J Hruby; Robert J Gillies; Eugene A Mash
Journal:  J Org Chem       Date:  2007-02-06       Impact factor: 4.354

6.  Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice.

Authors:  Kentaro Takayama; Tomo Asari; Mariko Saitoh; Kei Nirasawa; Eri Sasaki; Yoshimi Roppongi; Akari Nakamura; Yusuke Saga; Takahiro Shimada; Hiroaki Ikeyama; Akihiro Taguchi; Atsuhiko Taniguchi; Yoichi Negishi; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2019-05-28       Impact factor: 4.345

7.  Interaction of alpha-melanocyte stimulating hormone with binary phospholipid membranes: structural changes and relevance of phase behavior.

Authors:  L M Contreras; R F de Almeida; J Villalaín; A Fedorov; M Prieto
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

8.  Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Authors:  Lihui Wei; Yubin Miao; Fabio Gallazzi; Thomas P Quinn; Michael J Welch; Amy L Vāvere; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2007-09-04       Impact factor: 2.408

Review 9.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

Review 10.  Design of cyclized selective melanotropins.

Authors:  Minying Cai; Victor J Hruby
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.